Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Hydrocodone | The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Meptazinol. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Magnesium sulfate | The therapeutic efficacy of Meptazinol can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Meptazinol may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Orphenadrine | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Pramipexole | Meptazinol may increase the sedative activities of Pramipexole. |
| Ropinirole | Meptazinol may increase the sedative activities of Ropinirole. |
| Rotigotine | Meptazinol may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Meptazinol. |
| Sodium oxybate | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | The therapeutic efficacy of Tapentadol can be decreased when used in combination with Meptazinol. |
| Thalidomide | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Alvimopan | The risk or severity of adverse effects can be increased when Meptazinol is combined with Alvimopan. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Meptazinol is combined with Desmopressin. |
| Morphine | The therapeutic efficacy of Morphine can be decreased when used in combination with Meptazinol. |
| Codeine | The therapeutic efficacy of Codeine can be decreased when used in combination with Meptazinol. |
| Hydromorphone | The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Meptazinol. |
| Meperidine | The therapeutic efficacy of Meperidine can be decreased when used in combination with Meptazinol. |
| Oxycodone | The therapeutic efficacy of Oxycodone can be decreased when used in combination with Meptazinol. |
| Dextropropoxyphene | The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Meptazinol. |
| Naltrexone | The therapeutic efficacy of Meptazinol can be decreased when used in combination with Naltrexone. |
| Sufentanil | The therapeutic efficacy of Sufentanil can be decreased when used in combination with Meptazinol. |
| Alfentanil | The therapeutic efficacy of Alfentanil can be decreased when used in combination with Meptazinol. |
| Fentanyl | The therapeutic efficacy of Fentanyl can be decreased when used in combination with Meptazinol. |
| Levorphanol | The therapeutic efficacy of Levorphanol can be decreased when used in combination with Meptazinol. |
| Remifentanil | The therapeutic efficacy of Remifentanil can be decreased when used in combination with Meptazinol. |
| Diphenoxylate | The therapeutic efficacy of Diphenoxylate can be decreased when used in combination with Meptazinol. |
| Oxymorphone | The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Meptazinol. |
| Dezocine | The therapeutic efficacy of Dezocine can be decreased when used in combination with Meptazinol. |
| Methadyl acetate | The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with Meptazinol. |
| Dihydroetorphine | The therapeutic efficacy of Dihydroetorphine can be decreased when used in combination with Meptazinol. |
| Diamorphine | The therapeutic efficacy of Diamorphine can be decreased when used in combination with Meptazinol. |
| Bezitramide | The therapeutic efficacy of Bezitramide can be decreased when used in combination with Meptazinol. |
| Ethylmorphine | The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Meptazinol. |
| Etorphine | The therapeutic efficacy of Etorphine can be decreased when used in combination with Meptazinol. |
| Dextromoramide | The therapeutic efficacy of Dextromoramide can be decreased when used in combination with Meptazinol. |
| Desomorphine | The therapeutic efficacy of Desomorphine can be decreased when used in combination with Meptazinol. |
| Carfentanil | The therapeutic efficacy of Carfentanil can be decreased when used in combination with Meptazinol. |
| Dihydrocodeine | The therapeutic efficacy of Dihydrocodeine can be decreased when used in combination with Meptazinol. |
| Alphacetylmethadol | The therapeutic efficacy of Alphacetylmethadol can be decreased when used in combination with Meptazinol. |
| Dihydromorphine | The therapeutic efficacy of Dihydromorphine can be decreased when used in combination with Meptazinol. |
| Ketobemidone | The therapeutic efficacy of Ketobemidone can be decreased when used in combination with Meptazinol. |
| DPDPE | The therapeutic efficacy of DPDPE can be decreased when used in combination with Meptazinol. |
| Lofentanil | The therapeutic efficacy of Lofentanil can be decreased when used in combination with Meptazinol. |
| Opium | The therapeutic efficacy of Opium can be decreased when used in combination with Meptazinol. |
| Normethadone | The therapeutic efficacy of Normethadone can be decreased when used in combination with Meptazinol. |
| Piritramide | The therapeutic efficacy of Piritramide can be decreased when used in combination with Meptazinol. |
| Alphaprodine | The therapeutic efficacy of Alphaprodine can be decreased when used in combination with Meptazinol. |
| Nicomorphine | The therapeutic efficacy of Nicomorphine can be decreased when used in combination with Meptazinol. |
| Phenoperidine | The therapeutic efficacy of Phenoperidine can be decreased when used in combination with Meptazinol. |
| Phenazocine | The therapeutic efficacy of Phenazocine can be decreased when used in combination with Meptazinol. |
| Tilidine | The therapeutic efficacy of Tilidine can be decreased when used in combination with Meptazinol. |
| Carfentanil, C-11 | The therapeutic efficacy of Carfentanil, C-11 can be decreased when used in combination with Meptazinol. |
| Benzhydrocodone | The therapeutic efficacy of Benzhydrocodone can be decreased when used in combination with Meptazinol. |
| Pegvisomant | The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Meptazinol. |
| Succinylcholine | The risk or severity of bradycardia can be increased when Succinylcholine is combined with Meptazinol. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Meptazinol. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Meptazinol. |
| Methylnaltrexone | Meptazinol may increase the opioid antagonism activities of Methylnaltrexone. |
| Naloxegol | Meptazinol may increase the opioid antagonism activities of Naloxegol. |
| Mirtazapine | Meptazinol may increase the serotonergic activities of Mirtazapine. |
| Fluvoxamine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Fluvoxamine. |
| Citalopram | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Citalopram. |
| Duloxetine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Duloxetine. |
| Paroxetine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Paroxetine. |
| Sertraline | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Sertraline. |
| Sibutramine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Sibutramine. |
| Nefazodone | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Nefazodone. |
| Zimelidine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Zimelidine. |
| Dapoxetine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Dapoxetine. |
| Milnacipran | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Meptazinol. |
| Seproxetine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Levomilnacipran. |
| Indalpine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Indalpine. |
| Ritanserin | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Ritanserin. |
| Alaproclate | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Alaproclate. |
| Ethanol | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Meptazinol. |
| Phentermine | Phentermine may increase the analgesic activities of Meptazinol. |
| Pseudoephedrine | Pseudoephedrine may increase the analgesic activities of Meptazinol. |
| Benzphetamine | Benzphetamine may increase the analgesic activities of Meptazinol. |
| Diethylpropion | Diethylpropion may increase the analgesic activities of Meptazinol. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Lisdexamfetamine. |
| Mephentermine | Mephentermine may increase the analgesic activities of Meptazinol. |
| MMDA | MMDA may increase the analgesic activities of Meptazinol. |
| Midomafetamine | Midomafetamine may increase the analgesic activities of Meptazinol. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Meptazinol. |